Although previous studies have shown that P53 is mutated in approximately half of human tumours and PTEN mutation occurs in more than 20%, a substantial proportion of individuals without these mutations will also develop CRC.11, 12. This evidence concerns the gene PTEN and colorectal carcinoma.